GlassScriptPhysician profile
John A Santos
NPI 1114160272
$789.17
in general payments reported to CMS, 2019-2025
19 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.54 · 2022: $50.27 · 2023: $66.71 · 2024: $139 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $135.69 | 2025 | Mild Device Kit |
| Boston Scientific Corporation | $107.01 | 2024-2025 | Watchman Flx |
| Novo Nordisk INC | $81.78 | 2021-2025 | Rybelsus, Ozempic |
| Biosense Webster, INC. | $62.41 | 2025 | Carto 3 |
| Lilly USA, LLC | $44.67 | 2021-2024 | Zepbound, Mounjaro |
| Axsome Therapeutics, INC. | $43.54 | 2023 | Auvelity |
| Genentech USA, INC. | $41.17 | 2021 | |
| Organon LLC | $28.66 | 2025 | Vtama |
| Astrazeneca Pharmaceuticals LP | $28.00 | 2025 | Airsupra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.29 | 2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $23.60 | 2025 | Spravato |
| Exact Sciences Corporation | $23.46 | 2025 | The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $23.17 | 2023 | |
| Glaxosmithkline, LLC. | $22.34 | 2025 | Trelegy Ellipta, Arexvy |
| Photonicare INC | $21.82 | 2025 | Otosight Middle Ear Scope |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.15 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $20.18 | 2022 | |
| Pfizer INC. | $18.24 | 2024 | |
| Gilead Sciences, INC. | $15.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Santos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.